The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance–a focus on signaling pathways interplay
One of the most prevalent and lethal forms of gynecological cancer is ovarian cancer (OC),
which is often diagnosed in its latter, deadly stages. The OC's high mortality and …
which is often diagnosed in its latter, deadly stages. The OC's high mortality and …
[HTML][HTML] Candidate RNA biomarkers in biofluids for early diagnosis of ovarian cancer: A systematic review
Ovarian cancer is often diagnosed in an advanced stage and is associated with a high
mortality rate. It is assumed that early detection of ovarian cancer could improve patient …
mortality rate. It is assumed that early detection of ovarian cancer could improve patient …
[HTML][HTML] Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer
Ovarian cancer is mostly diagnosed at advantaged stages due to the lack of early diagnostic
biomarkers. The common metastasis pattern is characterized by peritoneal dissemination …
biomarkers. The common metastasis pattern is characterized by peritoneal dissemination …
Geniposide protects PC12 cells from lipopolysaccharide-evoked inflammatory injury via up-regulation of miR-145-5p
S Ma, C Zhang, Z Zhang, Y Dai, R Gu… - Artificial cells …, 2019 - Taylor & Francis
Geniposide is an active ingredient with anti-apoptotic and anti-inflammatory properties. This
study was to examine the effects of geniposide on a cell model of spinal cord injury (SCI) …
study was to examine the effects of geniposide on a cell model of spinal cord injury (SCI) …
miR-22 suppresses cell viability and EMT of ovarian cancer cells via NLRP3 and inhibits PI3K/AKT signaling pathway
H Wu, J Liu, Y Zhang, Q Li, Q Wang, Z Gu - Clinical and Translational …, 2021 - Springer
Purpose miR-22 plays a great role in inhibiting cell growth, metastasis and enhanced cell
apoptosis in several cancers. The purpose of this study was to investigate the functions of …
apoptosis in several cancers. The purpose of this study was to investigate the functions of …
Extracellular vesicle contents as non-invasive biomarkers in ovarian malignancies
Ovarian cancer most commonly presents at an advanced stage where survival is
approximately 30% compared with> 80% if diagnosed and treated before disease spreads …
approximately 30% compared with> 80% if diagnosed and treated before disease spreads …
Non-coding RNAs as biomarkers of tumor progression and metastatic spread in epithelial ovarian cancer
K Seborova, R Vaclavikova, L Rob, P Soucek… - Cancers, 2021 - mdpi.com
Simple Summary Despite advances in cancer research in recent years, efficient predictive
biomarkers of tumor progression and metastatic spread for ovarian cancer are still missing …
biomarkers of tumor progression and metastatic spread for ovarian cancer are still missing …
Toward More Comprehensive Homologous Recombination Deficiency Assays in Ovarian Cancer, Part 1: Technical Considerations
S Quesada, M Fabbro, J Solassol - Cancers, 2022 - mdpi.com
Simple Summary High-grade serous ovarian cancer (HGSOC) is the most frequent and
lethal form of ovarian cancer and is associated with homologous recombination deficiency …
lethal form of ovarian cancer and is associated with homologous recombination deficiency …
MicroRNA as biomarker in ovarian cancer management: Advantages and challenges
Ovarian cancer is the most prevalent gynecological malignancy affecting women throughout
the globe. Ovarian cancer has several subtypes, including epithelial ovarian cancer (EOC) …
the globe. Ovarian cancer has several subtypes, including epithelial ovarian cancer (EOC) …
Quercetin and MicroRNA interplay in apoptosis regulation in ovarian cancer
The multifaceted nature of ovarian cancer has severely hampered the development of
effective therapeutics over the years. The complicate nature of ovarian cancer makes it …
effective therapeutics over the years. The complicate nature of ovarian cancer makes it …